Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 16.7B | 13.7B | 11.1B | 9.2B |
Cost of revenue | 5.5B | 6.0B | 5.1B | 4.3B |
Gross profit | 11.2B | 7.6B | 6.0B | 4.8B |
Operating expense | ||||
Research & development | 245.7M | 189.6M | 178.0M | 187.7M |
Selling general and admin | — | 473.2M | 380.9M | 322.4M |
Other operating expenses | 3.4B | 922.6M | 721.8M | 559.9M |
Operating income | 3.7B | 3.0B | 2.2B | 1.6B |
Non operating interest income | ||||
Income | — | 118.4M | 59.7M | 22.9M |
Expense | 120.0M | 118.6M | 85.4M | 37.2M |
Other income expense | — | — | — | — |
Pretax income | 4.5B | 3.4B | 2.4B | 2.0B |
Tax provision | 1.1B | 860.1M | 582.1M | 487.4M |
Net income | 3.4B | 2.6B | 1.8B | 1.5B |
Basic EPS | — | 26.9 | 18.7 | 15.3 |
Diluted EPS | — | 26.9 | 18.7 | 15.3 |
Basic average shares | — | 95.9M | 95.9M | 95.9M |
Diluted average shares | — | 95.9M | 95.9M | 95.9M |
EBITDA | 5.5B | 4.0B | 3.1B | 2.4B |
Net income from continuing op. | 4.5B | 3.4B | 2.4B | 2.0B |
Minority interests | — | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |